GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sanara MedTech Inc (NAS:SMTI) » Definitions » Cyclically Adjusted PS Ratio

Sanara MedTech (Sanara MedTech) Cyclically Adjusted PS Ratio : 5.73 (As of Apr. 30, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Sanara MedTech Cyclically Adjusted PS Ratio?

As of today (2024-04-30), Sanara MedTech's current share price is $31.84. Sanara MedTech's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $5.56. Sanara MedTech's Cyclically Adjusted PS Ratio for today is 5.73.

The historical rank and industry rank for Sanara MedTech's Cyclically Adjusted PS Ratio or its related term are showing as below:

SMTI' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.71   Med: 3.41   Max: 12.08
Current: 5.83

During the past years, Sanara MedTech's highest Cyclically Adjusted PS Ratio was 12.08. The lowest was 0.71. And the median was 3.41.

SMTI's Cyclically Adjusted PS Ratio is ranked worse than
74.19% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs SMTI: 5.83

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sanara MedTech's adjusted revenue per share data for the three months ended in Dec. 2023 was $2.110. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $5.56 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sanara MedTech Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sanara MedTech's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanara MedTech Cyclically Adjusted PS Ratio Chart

Sanara MedTech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.88 11.97 6.91 9.30 7.39

Sanara MedTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.30 8.09 7.60 5.72 7.39

Competitive Comparison of Sanara MedTech's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Sanara MedTech's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanara MedTech's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sanara MedTech's Cyclically Adjusted PS Ratio falls into.



Sanara MedTech Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sanara MedTech's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=31.84/5.56
=5.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanara MedTech's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Sanara MedTech's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.11/129.4194*129.4194
=2.110

Current CPI (Dec. 2023) = 129.4194.

Sanara MedTech Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.779 99.695 1.011
201406 0.620 100.560 0.798
201409 0.764 100.428 0.985
201412 0.690 99.070 0.901
201503 0.954 99.621 1.239
201506 0.701 100.684 0.901
201509 0.844 100.392 1.088
201512 0.659 99.792 0.855
201603 1.010 100.470 1.301
201606 1.159 101.688 1.475
201609 1.300 101.861 1.652
201612 1.591 101.863 2.021
201703 0.774 102.862 0.974
201706 1.298 103.349 1.625
201709 1.393 104.136 1.731
201712 1.491 104.011 1.855
201803 1.235 105.290 1.518
201806 0.956 106.317 1.164
201809 0.662 106.507 0.804
201812 0.020 105.998 0.024
201903 5.907 107.251 7.128
201906 1.275 108.070 1.527
201909 1.230 108.329 1.469
201912 0.939 108.420 1.121
202003 0.568 108.902 0.675
202006 0.478 108.767 0.569
202009 0.686 109.815 0.808
202012 0.761 109.897 0.896
202103 0.735 111.754 0.851
202106 0.837 114.631 0.945
202109 0.775 115.734 0.867
202112 0.934 117.630 1.028
202203 1.027 121.301 1.096
202206 1.185 125.017 1.227
202209 1.609 125.227 1.663
202212 1.887 125.222 1.950
202303 1.899 127.348 1.930
202306 1.915 128.729 1.925
202309 1.923 129.860 1.916
202312 2.110 129.419 2.110

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sanara MedTech  (NAS:SMTI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sanara MedTech Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sanara MedTech's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanara MedTech (Sanara MedTech) Business Description

Traded in Other Exchanges
N/A
Address
1200 Summit Avenue, Suite 414, Fort Worth, TX, USA, 76102
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel.
Executives
Eric D Major director 751 MILLER DRIVE SE, LEESBURG VA 20175
Zachary B. Fleming officer: President - Surgical Div. 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Shawn M. Bowman officer: President - Wound Care Div. 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Rebecca E Mcmahon officer: President - R&D 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Sara N Ortwein director 5959 LAS COLINAS BOULEVARD, IRVING TX 75039-2298
Robert Andrew Desutter director 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Eric D Tanzberger director 1929 ALLEN PARKWAY, HOUSTON TX 77219
Christopher A. Morrison officer: President - Telehealth Svcs. 1200 SUMMIT AVENUE, SUITE 414, FORT WORTH TX 76102
Roszell Iii Mack director 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Cgi Cellerate Rx, Llc 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Catalyst Rochal, Llc 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Bradley J. Gurasich 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
J Michael Carmena director, officer: Principal Executive Officer 1200 SUMMIT AVE STE 414, FORT WORTH TX 76102
Michael D. Mcneil officer: Chief Financial Officer 1200 SUMMIT AVE, STE 414, FORT WORTH TX 76102
Catalyst Group, Inc. 10 percent owner 1375 ENCLAVE PARKWAY, HOUSTON TX 77077